{Reference Type}: Journal Article
{Title}: Nanoparticles in prevention of protein glycation.
{Author}: Sivaram A;Patil N;
{Journal}: Vitam Horm
{Volume}: 125
{Issue}: 0
{Year}: 2024
{Factor}: 2.247
{DOI}: 10.1016/bs.vh.2024.04.001
{Abstract}: Advanced glycation end products (AGEs) are formed by the non-enzymatic attachment of carbohydrates to a biological macromolecule. These AGEs bind to their cognate receptor called receptor for AGEs (RAGEs), which becomes one of the important causal factors for the initiation and progression of several diseases. A deep understanding into the pathways of RAGEs will help in identifying novel intervention modalities as a part of new therapeutic strategies. Although several approaches exist to target this pathway using small molecules, compounds of plant origin etc, nanoparticles have proven to be a critical method, given its several advantages. A high bioavailability, biocompatibility, ability to cross blood brain barrier and modifiable surface properties give nanoparticles an upper edge over other strategies. In this chapter, we will discuss AGEs, their involvement in diseases and the nanoparticles used for targeting this pathway.